Loyal
Backed by
Raised $22M Series B on Feb 26, 2025
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.
Explore similar companies to Loyal
Chai Discovery
Engineering better molecules using artificial intelligence.
Cortical Labs
Lab-grown neurons with silicon chips.
Cradle
Design better proteins.
Manifold Bio
Tissue-targeted medicines, designed in vivo.
Colossal
The de-extinction company.
Nudge
Whole-brain interfaces for everyday life.
Latent Labs
Making biology programmable.
Science
A brighter tomorrow enabled by neural engineering.
NewLimit
Extending human healthspan.